Lava Therapeutics NV
SEC CIK 1840748 · LVTX · last insider filing 2025-11-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hurly Stephen A | Director · Chief Executive Officer | filed 2025 - 2025 |
| Wilson Karen J | Director | filed 2025 - 2025 |
| Kiener Peter A | Director | filed 2025 - 2025 |
| Noble James | Director | filed 2025 - 2025 |
| Dhingra Kapil | Director | filed 2025 - 2025 |
| Backstrom Jay T. | Director | filed 2025 - 2025 |
| Wadlinger Mary E. | Director | filed 2025 - 2025 |
| Oliger Christy J. | Director | filed 2025 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Powell Fred M | Chief Financial Officer | filed 2025 - 2025 |
| Morris Charles Q | Chief Medical Officer | filed 2025 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.